NCT02538939

Brief Summary

Calcific tendinitis of the rotator cuff is a common cause of chronic pain of the shoulder. US- guided needling and lavage of the calcification is one of the therapeutic options after failure of conservative management with physiotherapy and anti-inflammatory drugs. The goal of this procedure is to remove the calcific deposit that is believed to cause the sub-acromial impingement. However, studies have shown that complete and rapid disappearance of the calcification deposit after irrigation is rare. The treatment is thought to promote the spontaneous resorption that occurs the weeks and months after the procedure. However, due to this slow process, time to complete recovery can be long. Moreover, it has been shown an association between the amount of removed calcium and improved outcome. Therefore, there is a need to find a way to remove quickly and completely the calcific deposit after irrigation. Sodium thiosulfate has been used successfully in the treatment of calciphylaxis and subcutaneous calcification deposit. The mechanism of action involves chelation of calcium into calcium thiosulfate salts which are much more soluble than other salts of calcium. Our hypothesis is that injection of sodium thiosulfate after irrigation of the calcification will help to dissolve the calcific deposit and thus prompt the disappearance of the calcification.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Dec 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 2, 2015

Completed
3 months until next milestone

Study Start

First participant enrolled

December 2, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 18, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 13, 2017

Completed
Last Updated

August 20, 2018

Status Verified

August 1, 2018

Enrollment Period

1.8 years

First QC Date

August 31, 2015

Last Update Submit

August 17, 2018

Conditions

Keywords

Calcific tendinitis, Shoulder, Needle lavage, Sodium thiosulfate

Outcome Measures

Primary Outcomes (1)

  • Decrease the size of the calcific deposit after the PFL

    Percentage of patient having more than 50% decrease in the size of the calcific deposit 1 month after the PFL

    1 month

Secondary Outcomes (7)

  • VAS pain during daily activity (0-10)

    7 days, 1 month and 3 months

  • VAS pain at rest (0-10)

    7 days, 1 month and 3 months

  • The Disabilities of the Arm, Shoulder and Hand (DASH) Score

    1 month and 3 months

  • Size of the calcific deposit assessed by X-Ray of the affected shoulder

    7 days, 1 month and 3 months

  • Size of the calcific deposit assessed by ultrasound of the affected shoulder

    7 days, 1 month and 3 months

  • +2 more secondary outcomes

Study Arms (1)

Injection of sodium thiosulfate

EXPERIMENTAL

Needling and lavage of calcific tendinitis of the rotator cuff followed by the injection of sodium thiosulfate

Drug: Sodium thiosulfate

Interventions

Injection of sodium thiosulfate

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Critères d'inclusion : * Patients de plus de 18 ans * Patients affiliés à un régime de sécurité sociale * Consentement éclairé et signé des patients * Douleur de l'épaule depuis plus de 3 mois * Douleur compatible avec une origine péri-articulaire : * aggravation lors de l'élévation de l'épaule * 1 des 3 tests de conflit sous-acromial positif (Yocum, Hawkins, Neer) * Présence d'une calcification dure \> 5 mm sur la radiographie standard (calcification de type A de la société Française d'Arthroscopie) (Mole, 1993) * Contraception efficace obligatoire pour les femmes en âge de procréer à maintenir jusqu'au lendemain de l'administration du thiosulfate de sodium. Critères de non-inclusion : * Allergie connue à l'anesthésique, au cortivazol ou au thiosulfate de sodium * Hypersensibilité connue au métabisulfite de sodium (agent de conservation et anti-oxydant connu sous le code E224) * Patients asthmatiques * Insuffisance rénale (Clairance \< 30 mL/min) * Patients sous anticoagulants, troubles de la coagulation * Tableau de résorption aiguë de la calcification (épaule aiguë hyperalgique) * Aspect flou de la calcification sur les radiographies standards évoquant une résorption (calcification de type C de la société Française d'Arthroscopie) (Mole, 1993) ou calcifications fragmentées à contours nets (type B) * Rupture de la coiffe des rotateurs mise en évidence sur l'échographie initiale * Antécédent de PFL sur la calcification étudiée dans les 3 mois précédent l'inclusion * Autre pathologie d'épaule associée (arthrose gléno-humérale, acromio-claviculaire), * Diabète déséquilibré * Contre-indication à la prise d'anti-inflammatoires non stéroïdiens et de paracétamol * Infection locale ou générale, ou suspicion d'infection * Contre-indication à la Xylocaïne 1% : (porphyrie récurrente, β-bloquant dans l'insuffisance cardiaque) * Femmes enceintes, mineurs, majeurs sous tutelle * Femmes en âge de procréer refusant de maintenir une contraception efficace jusqu'au lendemain de la PFL * Patients participant à un autre protocole de recherche clinique (à l'exception de recherches non-interventionnelles) * Patients incapables de suivre le protocole, selon le jugement de l'investigateur

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Nantes University Hospital

Nantes, 44000, France

Location

Related Publications (1)

  • Darrieurtort-Laffite C, Bertrand-Vasseur A, Garraud T, Planche L, Le Goff B. Tolerance and effect of sodium thiosulfate in calcific tendinitis of the rotator cuff. Clin Rheumatol. 2020 Feb;39(2):561-569. doi: 10.1007/s10067-019-04793-x. Epub 2019 Nov 1.

MeSH Terms

Interventions

sodium thiosulfate

Study Design

Study Type
interventional
Phase
phase 2
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 31, 2015

First Posted

September 2, 2015

Study Start

December 2, 2015

Primary Completion

September 18, 2017

Study Completion

November 13, 2017

Last Updated

August 20, 2018

Record last verified: 2018-08

Locations